Nanjing Well Pharmaceutical Group Co.,Ltd. (SHA:603351)
China · Delayed Price · Currency is CNY 22.92
-0.30 (-1.29%)
Jul 30, 2026, 3:00 PM CST
SHA:603351 Market Cap
SHA:603351 has a market cap or net worth of 3.14 billion as of July 30, 2026. Its market cap has decreased by -22.37% in one year.
Market Cap
3.14B
Enterprise Value
3.30B
Revenue
1.34B
Ranking
n/a
PE Ratio
20.73
Stock Price
22.92
ChartMarket Cap Chart
Since January 30, 2019, SHA:603351's market cap has decreased from 3.41B to 3.14B, a decrease of -7.72%. That is a compound annual growth rate of -1.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 3.14B | -10.76% |
| Dec 31, 2025 | 3.52B | 5.94% |
| Dec 31, 2024 | 3.33B | -6.86% |
| Dec 29, 2023 | 3.57B | 21.88% |
| Dec 30, 2022 | 2.93B | -42.75% |
| Dec 31, 2021 | 5.12B | 71.80% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shandong Wohua Pharmaceutical | 3.44B |
| Wuhan Hiteck Biological Pharma Co.,Ltd | 3.37B |
| Shaanxi Kanghui Pharmaceutical | 3.18B |
| Huaren Pharmaceutical | 3.14B |
| Zhejiang Cheng Yi Pharmaceutical | 3.13B |
| PKU HealthCare Corp.,Ltd. | 3.09B |
| Shanghai MicuRx Pharmaceutical | 3.03B |
| Tibet AIM Pharm. | 3.02B |